Skip to main content

Table 1 Data of 11 HAE patients gathered from chart review including demographics, comorbidities, HAE type and time of diagnosis

From: Impact of lanadelumab in hereditary angioedema: a case series of 12 patients in Canada

Case

Age

Sex

HAE Type

Comorbidities

Other medications

Age symptom onset (years)

Age HAE diagnosis (years)

1

25

M

1

Nil

Nil

18

18

2

24

M

1

Nil

Nil

1

4

3

42

F

1

SLE (quiescent)

Nil

10

23

4

38

F

2

Nil

Nil

11

2

5

36

F

1

Ulcerative Colitis

Nil

4

12

6

30

F

1

GERD, Chronic Pain

Methadone

23

25

7

59

F

1

Nil

Nil

26

59

8

34

F

1

Depression

Citalopram

11

11

9

50

F

1

Nil

Nil

47

48

10

74

F

1

Multiple Myeloma, HTN

Revlimid, Telmisartan

Unknown

55

11

44

F

1

Raynaud’s, GERD, Cervical Stenosis

Esomeprazole

15

33

12

65

M

1

T1DM, Primary Adrenal Insufficiency

Insulin

Pantoprazole

37

37

  1. GERD gastroesophageal reflux disease, SLE systemic lupus erythematosus, HTN hypertension, T1DM type 1 diabetes